Tag Archives: spin-out

Team of Experts from University of Liverpool Spin-Out Sulantrix Using AI and Multi-omics Platforms to Develop New Cancer Treatments

(IN BRIEF) A new spin-out drug discovery company from the University of Liverpool called Sulantrix is exploring new cancer medicines targeting previously untapped classes of pseudoenzymes. The company is led by Professor Patrick Eyers and CEO David Williams, who has … Read the full press release